Finanzen von Aspen Aerogels, Inc. (ASPN)ASPNAspen Aerogels, Inc.

Aspen Aerogels, Inc. (ASPN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Thermal barrier, accounting for 59.1% of total sales, equivalent to $29.48M. Another important revenue stream is Energy industrial. Understanding this composition is critical for investors evaluating how ASPN navigates market cycles within the Specialty Chemicals industry.

Evaluating the bottom line, Aspen Aerogels, Inc. maintains a gross margin of 17.22%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -29.20%, while the net margin is -46.67%. These profitability ratios, combined with a Return on Equity (ROE) of -50.36%, provide a clear picture of how effectively ASPN converts its operational activities into shareholder value.

In the context of the broader market, ASPN competes directly with industry leaders such as OPAL and MNTK. With a market capitalization of $434.03M, it holds a leading position in the sector. When comparing efficiency, ASPN's gross margin of 17.22% stands against OPAL's 23.15% and MNTK's 15.26%. Such benchmarking helps identify whether Aspen Aerogels, Inc. is trading at a premium or discount relative to its financial performance.

Aspen Aerogels has faced significant net losses, with a net income of -23.26 million USD in Q2 2026 and a gross margin of only 17.22%. However, revenue has shown signs of recovery, with a 32% increase quarter-over-quarter in Q2 2026.